Last revised by Daniel J Bell on 9 Dec 2022

Gadodiamide (brand name: Omniscan) is an extracellular intravenous contrast agent used in magnetic resonance imaging.

  • linear, non-ionic molecule 

  • 100% renally excreted

  • T1 relaxivity at 1.5 tesla: 4.0-4.6

  • concentration: 0.5 mmol/mL

  • recommended dosage: 0.1 mmol/kg


As an extracellular contrast agent, gadodiamide can be useful in a wide range of MRI applications, including (but not limited to): hepatic imaging, pelvic imaging, cardiac imaging, brain and spine imaging, and musculoskeletal imaging.


There is an association between the use of gadolinium-based contrast agents (GBCAs) in patients with kidney dysfunction and nephrogenic systemic fibrosis (NSF), a rare, but serious, condition. As a result, the use of three GBCAs; gadodiamide (Omniscan), gadopentetate dimeglumine (Magnevist), and gadoversetamide (OptiMARK) are contraindicated in patients with acute kidney injury or with chronic, severe kidney disease 2

ADVERTISEMENT: Supporters see fewer/no ads